NeoStem Inc.

Mr. Weinreb, an experienced chief executive officer and public company manager, oversees the Company's business and strategic initiatives. Mr. Weinreb joined the Company in February 2003 as Chairman of the Board of Directors, President and Chief Executive Officer, and in June 2006 continues as a Director and the Company's President. > read more

Ms. Vaczy joined the Company in April 2005 as Vice President and General Counsel. Ms. Vaczy is responsible for overseeing the Company's legal affairs as well as assisting the Company in reviewing and evaluating business, scientific and medical opportunities. > read more

Dr. Rodgerson joined the Company upon the closing of the Company's acquisition of the business of NeoStem, Inc. (California). Dr. Rodgerson, one of the original founders of NeoStem (California), Inc., has over 36 years' experience managing large tertiary care and reference clinical laboratories with many patents and articles to his credit. Prior to NeoStem (California), he co-founded StemCyte, and oversaw the company's growth to become the world's second largest umbilical cord stem cell bank with multinational collection centers. > read more

In October of 2006, Dr. Guerra was appointed Director of Sales and Marketing for NeoStem. As a pioneer in umbilical cord and placental stem cell science since the mid 1990s, Dr. Guerra brings extensive experience in healthcare marketing. He will be responsible for developing NeoStem's alliances with hospitals, physicians and health and wellness clinics nationwide for the establishment of adult stem cell collection centers. > read more

Dr. Losordo joined the Company s Scientific Advisory Board in October 2006. Dr. Losordo is a Professor of Medicine at Tufts University School of Medicine and Chief of Cardiovascular Research at St. Elizabeth s Medical Center in Boston, Dr. Lorsordo was recently appointed Professor of Medicine at Northwestern University and Director of the Feinberg Cardiovascular Research Institute and Program in Cardiovascular Regenerative Medicine. A Fellow or Member of many national professional organizations, he currently serves on committees of the American College of Cardiology, the American Diabetes Association and the American Society of Gene Therapy where he chairs the Cardiovascular Gene Therapy Committee. Dr. Losordo serves as Principal Investigator in many grant research projects and has published widely, contributing to more than 300 professional articles, abstracts and book chapters in recent years. He also serves on the Editorial Boards of numerous medical specialty journals including Stem Cells , Vascular Medicine and Circulation Research .

Dr. Zuckerman is Chairman of the Department of Orthopaedic Surgery at NYU Medical Center and the Hospital for Joint Diseases and is the Walter A. L. Thompson Professor of Orthopaedic Surgery at NYU School of Medicine. A graduate of Cornell University, he received his medical degree from the medical college of Wisconsin where he was a member of the Alpha Omega Alpha Medical Honor Society. He completed his residency in Orthopaedic Surgery at the University of Washington Affiliated Hospitals in Seattle. He then completed a fellowship in Adult Reconstructive Surgery/Arthritis Research at Harvard's Brigham and Women's Hospital in Boston and was a Visiting Clinician in shoulder surgery at the Mayo Clinic. Dr. Zuckerman joined the faculty of the Hospital for Joint Diseases in 1984 and was selected as an American-British-Canadian Traveling Fellow by the American Orthopaedic Association in 1991. In 1994, he was appointed Chairman of the Department of Orthopaedic Surgery and Surgeon-in-Chief. In 1997, he became Professor and Chairman of the NYU-Hospital for Joint Diseases Department of Orthopaedic Surgery. He currently serves as an editorial board member of several prominent orthopaedic and medical journals and is the author and editor of 11 orthopaedic textbooks and over 240 scientific articles. In addition, he maintains an active role in several national organizations. He is the past President of the American Shoulder and Elbow Surgeons. He has also served as Chair of the Council on Education for the American Academy of Orthopaedic Surgeons (AAOS) and recently completed a six year term as a member of the Board of Directors on the AAOS. Over the past twenty years, Dr. Zuckerman's research initiatives have focused primarily on the shoulder. In 1991, he established the Shoulder Research Group which has focused on the study of fractures about the shoulder, rotator cuff problems and the treatment of shoulder arthritis. He has been active in the design of a new prosthesis to treat glenohumeral arthritis, as well as shoulder fractures which has been in use since 2004.

Dr. Nimer is Professor of Medicine and Professor of Pharmacology at Weill Medical College of Cornell University. He also serves as Chief of Hematology Service and Head of the Division of Hematologic Oncology at Memorial Sloan-Kettering Cancer Center in New York City. Dr. Nimer is a member of many national professional organizations, including the American Society of Hematology, the American Society of Clinical Oncology, and the International Society for Stem Cell Research. He serves as a Reviewer for major medical journals, including the New England Journal of Medicine and the Journal of the American Medical Association (JAMA) among many others. He serves on numerous national and international Grant Review Committees and is a prominent invited speaker at conferences on his areas of expertise. He has authored or co-authored nearly 200 peer-reviewed papers, reviews, editorials and textbook chapters, primarily focused on issues concerning hematology and oncology